Skip to Main Content
Legislation Search

S. 2005: IDeA Reauthorization Act of 2025

The IDeA Reauthorization Act of 2025 aims to enhance the Institutional Development Award (IDeA) program within the National Institutes of Health (NIH). This program focuses on supporting biomedical and behavioral research in states that traditionally receive lower funding from NIH, referred to as IDeA States. The key components of the bill include:

Definition and Purpose of the IDeA Program

The bill formally identifies and clarifies the purpose of the IDeA program, which is to support research institutions in certain states that are below the median in aggregate NIH grant funding. This helps ensure that these states are better integrated into the broader scientific research community.

Annual Reporting Requirements

The bill mandates that the NIH provide detailed reports to Congress as part of its annual budget submission. This report must include several aspects:

  • A comprehensive description of the strategy and objectives of the IDeA program.
  • A summary of the awards granted in the previous fiscal year, which should encompass:
    • The efforts to integrate IDeA States into major NIH activities.
    • The percentage of reviewers for IDeA program awards who come from IDeA States.
    • Updates on collaborative programs involving institutions from both IDeA and non-IDeA States.
  • A review of improvements in research quality and development of biomedical science professionals attributed to the IDeA program over the last five years.

Impact on Research Institutions

This legislation is intended to strengthen the research capabilities and outputs of institutions located in IDeA States, thereby enhancing their contributions to the scientific community and biomedical research as a whole.

Relevant Companies

  • None found

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

4 bill sponsors

Actions

2 actions

Date Action
Jun. 10, 2025 Introduced in Senate
Jun. 10, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

No relevant congressional stock trades found.